Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children

Comparing to adult inflammatory bowel disease (IBD), those with early onset manifestations have different features in terms of the underlying molecular pathology, the course of disease and the response to therapy. We investigated the IL-10 signaling pathway previously reported as an important cause...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medical genetics 2017-12, Vol.60 (12), p.643-649
Hauptverfasser: Nemati, Shahram, Teimourian, Shahram, Tabrizi, Mina, Najafi, Mehri, Dara, Naghi, Imanzadeh, Farid, Ahmadi, Mitra, Aghdam, Maryam Kazemi, Tavassoli, Mohmoud, Rohani, Pejman, Madani, Seyyed Ramin, de Boer, Martin, Kuijpers, T.W., Roos, Dirk
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 649
container_issue 12
container_start_page 643
container_title European journal of medical genetics
container_volume 60
creator Nemati, Shahram
Teimourian, Shahram
Tabrizi, Mina
Najafi, Mehri
Dara, Naghi
Imanzadeh, Farid
Ahmadi, Mitra
Aghdam, Maryam Kazemi
Tavassoli, Mohmoud
Rohani, Pejman
Madani, Seyyed Ramin
de Boer, Martin
Kuijpers, T.W.
Roos, Dirk
description Comparing to adult inflammatory bowel disease (IBD), those with early onset manifestations have different features in terms of the underlying molecular pathology, the course of disease and the response to therapy. We investigated the IL-10 signaling pathway previously reported as an important cause of infantile (Very Early Onset) IBD to find any possible variants. With the next generation sequencing technique we screened IL-10, IL-10RA and IL10RB genes of 15 children affected by very early onset-GI (gastrointestinal) disorders. Additionally, we analyzed them based on Thermo Fisher immune deficiency panel for genes either having a known role in IBD pathogenesis or cause the disorders with overlapping manifestations. We performed multiple functional analyses only for the cases showing variants in IL-10- related genes. In 3 out of 15 patients we identified variants including a homozygous and heterozygote mutations in IL-10RA and a novel homozygous mutation in IL-12RB1. Our functional studies reveal that in contrast to the IL-10RA heterozygote mutation that does not have deleterious effects, the homozygous mutation abrogates the IL-10 signaling pathway. Our study suggests we need to modify the classical diagnostic approach from functional assays followed by candidate- gene or genes sequencing to the firstly parallel genomic screening followed by functional studies.
doi_str_mv 10.1016/j.ejmg.2017.08.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1936163434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1769721217302434</els_id><sourcerecordid>1936163434</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-ee7b36d2bc5875b256cb891677c2a386b6857e0ecb40b0ba8801d88d1487d3a43</originalsourceid><addsrcrecordid>eNp9kE1vEzEQhi0EoqXwBzggH7ns4o9dexZxQRXQSJG4AFfLH5PE0a432JtW-fd1lMKxpxnNvO-jmZeQ95y1nHH1ad_iftq2gnHdMmjr6AW55qChYdANL2uv1dBowcUVeVPKnjEJXAyvyZUAUB3XcE2mP5hPFG0eT3ROBRca02a002SXuS7c_IAjDbGgLfiZrtI9liVu7RLnROcNXXZIV-uGM1riNtkxpi092GX3YE8VRFfZpmgT9bs4hozpLXm1sWPBd0_1hvz-_u3X7V2z_vljdft13XjZq6VB1E6qIJzvQfdO9Mo7GLjS2gsrQTkFvUaG3nXMMWcBGA8AgXegg7SdvCEfL9xDnv8e68lmisXjONqE87EYPkjFlezkWSouUp_nUjJuzCHHyeaT4cycYzZ7c47ZnGM2DEwdVdOHJ_7RTRj-W_7lWgVfLgKsX95HzKb4iMljiBn9YsIcn-M_AjlSjvc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1936163434</pqid></control><display><type>article</type><title>Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Nemati, Shahram ; Teimourian, Shahram ; Tabrizi, Mina ; Najafi, Mehri ; Dara, Naghi ; Imanzadeh, Farid ; Ahmadi, Mitra ; Aghdam, Maryam Kazemi ; Tavassoli, Mohmoud ; Rohani, Pejman ; Madani, Seyyed Ramin ; de Boer, Martin ; Kuijpers, T.W. ; Roos, Dirk</creator><creatorcontrib>Nemati, Shahram ; Teimourian, Shahram ; Tabrizi, Mina ; Najafi, Mehri ; Dara, Naghi ; Imanzadeh, Farid ; Ahmadi, Mitra ; Aghdam, Maryam Kazemi ; Tavassoli, Mohmoud ; Rohani, Pejman ; Madani, Seyyed Ramin ; de Boer, Martin ; Kuijpers, T.W. ; Roos, Dirk</creatorcontrib><description>Comparing to adult inflammatory bowel disease (IBD), those with early onset manifestations have different features in terms of the underlying molecular pathology, the course of disease and the response to therapy. We investigated the IL-10 signaling pathway previously reported as an important cause of infantile (Very Early Onset) IBD to find any possible variants. With the next generation sequencing technique we screened IL-10, IL-10RA and IL10RB genes of 15 children affected by very early onset-GI (gastrointestinal) disorders. Additionally, we analyzed them based on Thermo Fisher immune deficiency panel for genes either having a known role in IBD pathogenesis or cause the disorders with overlapping manifestations. We performed multiple functional analyses only for the cases showing variants in IL-10- related genes. In 3 out of 15 patients we identified variants including a homozygous and heterozygote mutations in IL-10RA and a novel homozygous mutation in IL-12RB1. Our functional studies reveal that in contrast to the IL-10RA heterozygote mutation that does not have deleterious effects, the homozygous mutation abrogates the IL-10 signaling pathway. Our study suggests we need to modify the classical diagnostic approach from functional assays followed by candidate- gene or genes sequencing to the firstly parallel genomic screening followed by functional studies.</description><identifier>ISSN: 1769-7212</identifier><identifier>EISSN: 1878-0849</identifier><identifier>DOI: 10.1016/j.ejmg.2017.08.016</identifier><identifier>PMID: 28864178</identifier><language>eng</language><publisher>Netherlands: Elsevier Masson SAS</publisher><subject>Age of Onset ; Child, Preschool ; Female ; Genomic screening ; Homozygote ; Humans ; IL-10 signaling pathway ; Infantile IBD ; Inflammatory Bowel Diseases - genetics ; Inflammatory Bowel Diseases - pathology ; Interleukin-10 - genetics ; Interleukin-10 Receptor alpha Subunit - genetics ; Interleukin-10 Receptor beta Subunit - genetics ; Iran ; Male ; Mutation ; Signal Transduction ; Very early onset inflammatory bowel disease</subject><ispartof>European journal of medical genetics, 2017-12, Vol.60 (12), p.643-649</ispartof><rights>2017 Elsevier Masson SAS</rights><rights>Copyright © 2017 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-ee7b36d2bc5875b256cb891677c2a386b6857e0ecb40b0ba8801d88d1487d3a43</citedby><cites>FETCH-LOGICAL-c356t-ee7b36d2bc5875b256cb891677c2a386b6857e0ecb40b0ba8801d88d1487d3a43</cites><orcidid>0000-0002-2723-7978</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmg.2017.08.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28864178$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nemati, Shahram</creatorcontrib><creatorcontrib>Teimourian, Shahram</creatorcontrib><creatorcontrib>Tabrizi, Mina</creatorcontrib><creatorcontrib>Najafi, Mehri</creatorcontrib><creatorcontrib>Dara, Naghi</creatorcontrib><creatorcontrib>Imanzadeh, Farid</creatorcontrib><creatorcontrib>Ahmadi, Mitra</creatorcontrib><creatorcontrib>Aghdam, Maryam Kazemi</creatorcontrib><creatorcontrib>Tavassoli, Mohmoud</creatorcontrib><creatorcontrib>Rohani, Pejman</creatorcontrib><creatorcontrib>Madani, Seyyed Ramin</creatorcontrib><creatorcontrib>de Boer, Martin</creatorcontrib><creatorcontrib>Kuijpers, T.W.</creatorcontrib><creatorcontrib>Roos, Dirk</creatorcontrib><title>Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children</title><title>European journal of medical genetics</title><addtitle>Eur J Med Genet</addtitle><description>Comparing to adult inflammatory bowel disease (IBD), those with early onset manifestations have different features in terms of the underlying molecular pathology, the course of disease and the response to therapy. We investigated the IL-10 signaling pathway previously reported as an important cause of infantile (Very Early Onset) IBD to find any possible variants. With the next generation sequencing technique we screened IL-10, IL-10RA and IL10RB genes of 15 children affected by very early onset-GI (gastrointestinal) disorders. Additionally, we analyzed them based on Thermo Fisher immune deficiency panel for genes either having a known role in IBD pathogenesis or cause the disorders with overlapping manifestations. We performed multiple functional analyses only for the cases showing variants in IL-10- related genes. In 3 out of 15 patients we identified variants including a homozygous and heterozygote mutations in IL-10RA and a novel homozygous mutation in IL-12RB1. Our functional studies reveal that in contrast to the IL-10RA heterozygote mutation that does not have deleterious effects, the homozygous mutation abrogates the IL-10 signaling pathway. Our study suggests we need to modify the classical diagnostic approach from functional assays followed by candidate- gene or genes sequencing to the firstly parallel genomic screening followed by functional studies.</description><subject>Age of Onset</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>Genomic screening</subject><subject>Homozygote</subject><subject>Humans</subject><subject>IL-10 signaling pathway</subject><subject>Infantile IBD</subject><subject>Inflammatory Bowel Diseases - genetics</subject><subject>Inflammatory Bowel Diseases - pathology</subject><subject>Interleukin-10 - genetics</subject><subject>Interleukin-10 Receptor alpha Subunit - genetics</subject><subject>Interleukin-10 Receptor beta Subunit - genetics</subject><subject>Iran</subject><subject>Male</subject><subject>Mutation</subject><subject>Signal Transduction</subject><subject>Very early onset inflammatory bowel disease</subject><issn>1769-7212</issn><issn>1878-0849</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1vEzEQhi0EoqXwBzggH7ns4o9dexZxQRXQSJG4AFfLH5PE0a432JtW-fd1lMKxpxnNvO-jmZeQ95y1nHH1ad_iftq2gnHdMmjr6AW55qChYdANL2uv1dBowcUVeVPKnjEJXAyvyZUAUB3XcE2mP5hPFG0eT3ROBRca02a002SXuS7c_IAjDbGgLfiZrtI9liVu7RLnROcNXXZIV-uGM1riNtkxpi092GX3YE8VRFfZpmgT9bs4hozpLXm1sWPBd0_1hvz-_u3X7V2z_vljdft13XjZq6VB1E6qIJzvQfdO9Mo7GLjS2gsrQTkFvUaG3nXMMWcBGA8AgXegg7SdvCEfL9xDnv8e68lmisXjONqE87EYPkjFlezkWSouUp_nUjJuzCHHyeaT4cycYzZ7c47ZnGM2DEwdVdOHJ_7RTRj-W_7lWgVfLgKsX95HzKb4iMljiBn9YsIcn-M_AjlSjvc</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Nemati, Shahram</creator><creator>Teimourian, Shahram</creator><creator>Tabrizi, Mina</creator><creator>Najafi, Mehri</creator><creator>Dara, Naghi</creator><creator>Imanzadeh, Farid</creator><creator>Ahmadi, Mitra</creator><creator>Aghdam, Maryam Kazemi</creator><creator>Tavassoli, Mohmoud</creator><creator>Rohani, Pejman</creator><creator>Madani, Seyyed Ramin</creator><creator>de Boer, Martin</creator><creator>Kuijpers, T.W.</creator><creator>Roos, Dirk</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2723-7978</orcidid></search><sort><creationdate>201712</creationdate><title>Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children</title><author>Nemati, Shahram ; Teimourian, Shahram ; Tabrizi, Mina ; Najafi, Mehri ; Dara, Naghi ; Imanzadeh, Farid ; Ahmadi, Mitra ; Aghdam, Maryam Kazemi ; Tavassoli, Mohmoud ; Rohani, Pejman ; Madani, Seyyed Ramin ; de Boer, Martin ; Kuijpers, T.W. ; Roos, Dirk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-ee7b36d2bc5875b256cb891677c2a386b6857e0ecb40b0ba8801d88d1487d3a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Age of Onset</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>Genomic screening</topic><topic>Homozygote</topic><topic>Humans</topic><topic>IL-10 signaling pathway</topic><topic>Infantile IBD</topic><topic>Inflammatory Bowel Diseases - genetics</topic><topic>Inflammatory Bowel Diseases - pathology</topic><topic>Interleukin-10 - genetics</topic><topic>Interleukin-10 Receptor alpha Subunit - genetics</topic><topic>Interleukin-10 Receptor beta Subunit - genetics</topic><topic>Iran</topic><topic>Male</topic><topic>Mutation</topic><topic>Signal Transduction</topic><topic>Very early onset inflammatory bowel disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nemati, Shahram</creatorcontrib><creatorcontrib>Teimourian, Shahram</creatorcontrib><creatorcontrib>Tabrizi, Mina</creatorcontrib><creatorcontrib>Najafi, Mehri</creatorcontrib><creatorcontrib>Dara, Naghi</creatorcontrib><creatorcontrib>Imanzadeh, Farid</creatorcontrib><creatorcontrib>Ahmadi, Mitra</creatorcontrib><creatorcontrib>Aghdam, Maryam Kazemi</creatorcontrib><creatorcontrib>Tavassoli, Mohmoud</creatorcontrib><creatorcontrib>Rohani, Pejman</creatorcontrib><creatorcontrib>Madani, Seyyed Ramin</creatorcontrib><creatorcontrib>de Boer, Martin</creatorcontrib><creatorcontrib>Kuijpers, T.W.</creatorcontrib><creatorcontrib>Roos, Dirk</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medical genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nemati, Shahram</au><au>Teimourian, Shahram</au><au>Tabrizi, Mina</au><au>Najafi, Mehri</au><au>Dara, Naghi</au><au>Imanzadeh, Farid</au><au>Ahmadi, Mitra</au><au>Aghdam, Maryam Kazemi</au><au>Tavassoli, Mohmoud</au><au>Rohani, Pejman</au><au>Madani, Seyyed Ramin</au><au>de Boer, Martin</au><au>Kuijpers, T.W.</au><au>Roos, Dirk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children</atitle><jtitle>European journal of medical genetics</jtitle><addtitle>Eur J Med Genet</addtitle><date>2017-12</date><risdate>2017</risdate><volume>60</volume><issue>12</issue><spage>643</spage><epage>649</epage><pages>643-649</pages><issn>1769-7212</issn><eissn>1878-0849</eissn><abstract>Comparing to adult inflammatory bowel disease (IBD), those with early onset manifestations have different features in terms of the underlying molecular pathology, the course of disease and the response to therapy. We investigated the IL-10 signaling pathway previously reported as an important cause of infantile (Very Early Onset) IBD to find any possible variants. With the next generation sequencing technique we screened IL-10, IL-10RA and IL10RB genes of 15 children affected by very early onset-GI (gastrointestinal) disorders. Additionally, we analyzed them based on Thermo Fisher immune deficiency panel for genes either having a known role in IBD pathogenesis or cause the disorders with overlapping manifestations. We performed multiple functional analyses only for the cases showing variants in IL-10- related genes. In 3 out of 15 patients we identified variants including a homozygous and heterozygote mutations in IL-10RA and a novel homozygous mutation in IL-12RB1. Our functional studies reveal that in contrast to the IL-10RA heterozygote mutation that does not have deleterious effects, the homozygous mutation abrogates the IL-10 signaling pathway. Our study suggests we need to modify the classical diagnostic approach from functional assays followed by candidate- gene or genes sequencing to the firstly parallel genomic screening followed by functional studies.</abstract><cop>Netherlands</cop><pub>Elsevier Masson SAS</pub><pmid>28864178</pmid><doi>10.1016/j.ejmg.2017.08.016</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2723-7978</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1769-7212
ispartof European journal of medical genetics, 2017-12, Vol.60 (12), p.643-649
issn 1769-7212
1878-0849
language eng
recordid cdi_proquest_miscellaneous_1936163434
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Age of Onset
Child, Preschool
Female
Genomic screening
Homozygote
Humans
IL-10 signaling pathway
Infantile IBD
Inflammatory Bowel Diseases - genetics
Inflammatory Bowel Diseases - pathology
Interleukin-10 - genetics
Interleukin-10 Receptor alpha Subunit - genetics
Interleukin-10 Receptor beta Subunit - genetics
Iran
Male
Mutation
Signal Transduction
Very early onset inflammatory bowel disease
title Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A18%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Very%20early%20onset%20inflammatory%20bowel%20disease:%20Investigation%20of%20the%20IL-10%20signaling%20pathway%20in%20Iranian%20children&rft.jtitle=European%20journal%20of%20medical%20genetics&rft.au=Nemati,%20Shahram&rft.date=2017-12&rft.volume=60&rft.issue=12&rft.spage=643&rft.epage=649&rft.pages=643-649&rft.issn=1769-7212&rft.eissn=1878-0849&rft_id=info:doi/10.1016/j.ejmg.2017.08.016&rft_dat=%3Cproquest_cross%3E1936163434%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1936163434&rft_id=info:pmid/28864178&rft_els_id=S1769721217302434&rfr_iscdi=true